Funding Received
$32 Million in 1 Round from 7 Investors
Most Recent Funding
$32 Million Series A on September 30, 2008
Headquarters:
Burlingame, CA
Description:
APT Pharmaceuticals is a drug-development company focused on treatments for significant unmet medical needs.
Founders:
Stephen G. Dilly
Categories:
Biotechnology
Website:
http://www.aptbio.com

Detailed Description

Update

APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Past Team (3)

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    700 Airport Blvd

    Suite 350

    Burlingame, CA 94010

    USA

Images (1)

Update
  • 8e5d7cf2c211291a0f18a75db803cbcd